About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Expert Review of Anticancer Therapy
›
Top Articles
Expert Review of Anticancer Therapy
Oncology
,
Pharmacology
3.5
(top 4%)
Impact Factor
3.8
(top 4%)
extended IF
72
(top 5%)
H-Index
1.7K
authors
2.5K
papers
41.5K
citations
4.2K
citing journals
32.1K
citing authors
Most Cited Articles of Expert Review of Anticancer Therapy
Title
Year
Citations
Current and future therapeutic approaches for osteosarcoma
2018
342
HER2-amplified breast cancer: mechanisms of trastuzumab resistance and novel targeted therapies
2011
282
Chemotherapy resistance in osteosarcoma: current challenges and future directions
2006
276
Tariquidar (XR9576): a P-glycoprotein drug efflux pump inhibitor
2007
253
Nonhistone protein acetylation as cancer therapy targets
2010
208
Inflammation in the development of lung cancer: epidemiological evidence
2008
197
A new understanding in the epidemiology of melanoma
2010
185
Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors
2010
175
Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy
2009
168
Head and neck cancer: past, present and future
2006
158
Overview and recent advances in the treatment of neuroblastoma
2017
157
Antivascular effects of electrochemotherapy: implications in treatment of bleeding metastases
2010
146
Nanotechnology for targeted cancer therapy
2007
146
The role of platelet activation in tumor metastasis
2008
143
Metastatic osteosarcoma: a challenging multidisciplinary treatment
2016
132
Current systemic therapy for metastatic melanoma
2009
132
Development of histone deacetylase inhibitors for cancer treatment
2007
130
Oncolytic viruses: a novel form of immunotherapy
2008
129
Molecular neuro-oncology and development of targeted therapeutic strategies for brain tumors. Part 2: PI3K/Akt/PTEN, mTOR, SHH/PTCH and angiogenesis
2004
124
Stathmin 1: a novel therapeutic target for anticancer activity
2008
118
Autophagy and endocrine resistance in breast cancer
2011
113
Recent advances in the prevention and treatment of skin cancer using photodynamic therapy
2010
110
New treatment strategies for malignant gliomas
2006
108
Recently elucidated energy catabolism pathways provide opportunities for novel treatments in hepatocellular carcinoma
2004
108
The role of Gliadel wafers in the treatment of high-grade gliomas
2013
107
previous
2015
2016
2017
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.